One of my best friends just passed a couple of days ago from pancreatic cancer. She had tried getting into the kevetrin trial shortly after diagnosis. However, Dana Farber wouldn't take her since she hadn't tried anything else. So, the odds are high the current patient in the trial with pancreatic cancer had already tried other treatment options that failed.
In Reply to 'RJFL'
Aloha BigKahuna- I hope so as well. Considering that acceptance in the current trial entails "locally advanced or metastatic, either refractory after standard therapy, or for which no effective curative or surgical treatment options are available", it's very possible the pancreatic cancer patient in the trial might very well have already tried/failed other treatments such as Gemcitabine. This begs the question, what are the statistical probabilities for achieving a 4+ month stabilization in that scenario? Ii really hope "K" can be of help to pancreatic cancer patients because there are no real effective treatment options if the disease is advanced.
News 
Market Data 
Discover 
